LLY

Eli Lilly's total return topped 367% over the past five years, largely thanks to enthusiasm for its GLP-1 offerings.

Yahoo · 21h ago

Fundamentals, not a stock split, will determine whether the bull case for Eli Lilly continues.

Yahoo · 23h ago

CRISPR Therapeutics' current $5.6B market cap and $1.78B net cash position offer acquisition appeal. Click to know why CRSP is rated a Buy.

SeekingAlpha · 1d ago

Eli Lilly (LLY) stock looks attractive vs. overextended semiconductors, with strong Q2 growth and reasonable PEG. See here for more details.

SeekingAlpha · 1d ago

Eli Lilly and Company (NYSE:LLY) has launched Foundayo in the United Kingdom, making Britain the first European country where the company’s oral treatment for weight management and type 2 diabetes is available. The pill, known chemically as orforglipron, became available through private prescription after the UK medicines regulator authorised it on August 10. Its launch […]

Yahoo · 1d ago

Testing for Alzheimer’s-related brain changes has traditionally depended on procedures that can be expensive, invasive, or difficult to access. Roche Holding AG and Eli Lilly and Company (NYSE:LLY) may now have a simpler way to help physicians evaluate certain patients. The FDA has cleared Elecsys pTau217, which is a blood test that helps identify whether […]

Yahoo · 1d ago

The portfolio looks diversified. Cramer says look again

Yahoo · 1d ago